Is Clene Stock a Good Investment?

Clene Investment Advice

CLNNW

To provide specific investment advice or recommendations on Clene Inc stock, we recommend investors consider the following general factors when evaluating Clene Inc. This will help you to make an informed decision on whether to include Clene in one of your diversified portfolios:

Examine Clene's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Clene's leadership team and their track record. Good management can help Clene navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Biotechnology space and any emerging trends that could impact Clene's business and its evolving consumer preferences.
Compare Clene's performance and market position to its competitors. Analyze how Clene is positioned in terms of product offerings, innovation, and market share.
Check if Clene pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Clene's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in Clene Inc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Clene Inc is a good investment.

Sell

Buy

Strong Sell

We provide trade advice to complement the prevailing expert consensus on Clene Inc. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Clene is not overpriced, please confirm all Clene Inc fundamentals, including its cash and equivalents, as well as the relationship between the number of employees and net asset . As Clene Inc appears to be a penny stock we also recommend to validate its debt to equity numbers.

Market Performance	Insignificant	Details
Volatility	Out of control	Details
Hype Condition	Under hyped	Details
Current Valuation	Overvalued	Details
Odds Of Distress	Below Average	Details
Economic Sensitivity	Moves completely opposite to the market	Details
Investor Sentiment	Interested	Details
Analyst Consensus	Not Available	Details
Financial Strenth (F Score)	Poor	Details
Financial Leverage	Inapplicable	Details
Reporting Quality (M-Score)	Unlikely Manipulator	Details

Examine Clene Stock

Researching Clene's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company had not issued any dividends in recent years. Clene Inc had 1:1 split on the 31st of December 2020.

To determine if Clene is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Clene's research are outlined below:

	Clene Inc is way too risky over 90 days horizon
	Clene Inc has some characteristics of a very speculative penny stock
	Clene Inc appears to be risky and price may revert if volatility continues
	The company reported the revenue of 654 K. Net Loss for the year was (49.5 M) with profit before overhead, payroll, taxes, and interest of 0.
	Clene Inc has accumulated about 36.78 M in cash with (30.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
	Clene Inc has a poor financial position based on the latest SEC disclosures

Clene's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 646.98 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Clene's market, we take the total number of its shares issued and multiply it by Clene's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Market Cap

34 Million

Clene's profitablity analysis

Clene's profitability indicators refer to fundamental financial ratios that showcase Clene's ability to generate income relative to its revenue or operating costs. If, let's say, Clene is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Clene's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Clene's profitability requires more research than a typical breakdown of Clene's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.

	Last Reported	Projected for Next Year
Return On Tangible Assets	(0.95)	(0.90)
Return On Capital Employed	(1.50)	(1.58)
Return On Assets	(0.95)	(0.90)
Return On Equity	(3.70)	(3.88)

Determining Clene's profitability involves analyzing its financial statements and using various financial metrics to determine if Clene is a good buy. For example, gross profit margin measures Clene's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Clene's profitability and make more informed investment decisions.

The data published in Clene's official financial statements usually reflect Clene's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Clene Inc. For example, before you start analyzing numbers published by Clene accountants, it's critical to develop an understanding of what Clene's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.

Please note, the presentation of Clene's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Clene's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Clene's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Clene Inc. Please utilize our Beneish M Score to check the likelihood of Clene's management manipulating its earnings.

Evaluate Clene's management efficiency

Clene Inc has return on total asset (ROA) of (0.5233) % which means that it has lost $0.5233 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (5.9547) %, meaning that it generated substantial loss on money invested by shareholders. Clene's management efficiency ratios could be used to measure how well Clene manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to -0.9 in 2024. Return On Capital Employed is likely to drop to -1.58 in 2024. At this time, Clene's Non Currrent Assets Other are fairly stable compared to the past year. Net Tangible Assets is likely to climb to about 5.9 M in 2024, whereas Other Current Assets are likely to drop slightly above 1.6 M in 2024.

	Last Reported	Projected for Next Year
Book Value Per Share	0.13	0.13
Net Current Asset Value	0.00	0.00
Tangible Asset Value	0.00	0.00
Tangible Book Value Per Share	0.13	0.13
Enterprise Value Over EBITDA	(0.89)	(0.93)
Price Book Value Ratio	2.32	2.21
Enterprise Value Multiple	(0.89)	(0.93)
Price Fair Value	2.32	2.21
Enterprise Value	39.6 M	37.7 M

The analysis of Clene's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Clene's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Clene Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.

Beta

0.488

Basic technical analysis of Clene Stock

As of the 27th of April, Clene shows the risk adjusted performance of 0.1036, and Mean Deviation of 14.89. Clene Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for Clene Inc, which can be compared to its peers. Please confirm Clene Inc market risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Clene Inc is priced correctly, providing market reflects its regular price of 0.0665 per share. As Clene Inc appears to be a penny stock we also recommend to validate its total risk alpha numbers.

Clene's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Clene insiders, such as employees or executives, is commonly permitted as long as it does not rely on Clene's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Clene insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

		Mosca Alison over a month ago Acquisition by Mosca Alison of 12430 shares of Clene at 1.62 subject to Rule 16b-3
		Ugwumba Chidozie over a month ago Acquisition by Ugwumba Chidozie of 990099 shares of Clene at 1.01 subject to Rule 16b-3

Understand Clene's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Clene's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	0.1036
	Market Risk Adjusted Performance	(0.49)
	Mean Deviation	14.89
	Semi Deviation	13.31
	Downside Deviation	16.43
	Coefficient Of Variation	664.52
	Standard Deviation	18.74
	Variance	351.3
	Information Ratio	0.1457
	Jensen Alpha	3.25
	Total Risk Alpha	0.431
	Sortino Ratio	0.1662
	Treynor Ratio	(0.50)
	Maximum Drawdown	75.8
	Value At Risk	(27.05)
	Potential Upside	35.21
	Downside Variance	270.1
	Semi Variance	177.27
	Expected Short fall	(19.99)
	Skewness	0.2869
	Kurtosis	(0.41)

	Risk Adjusted Performance	0.1036
	Market Risk Adjusted Performance	(0.49)
	Mean Deviation	14.89
	Semi Deviation	13.31
	Downside Deviation	16.43
	Coefficient Of Variation	664.52
	Standard Deviation	18.74
	Variance	351.3
	Information Ratio	0.1457
	Jensen Alpha	3.25
	Total Risk Alpha	0.431
	Sortino Ratio	0.1662
	Treynor Ratio	(0.50)
	Maximum Drawdown	75.8
	Value At Risk	(27.05)
	Potential Upside	35.21
	Downside Variance	270.1
	Semi Variance	177.27
	Expected Short fall	(19.99)
	Skewness	0.2869
	Kurtosis	(0.41)

Consider Clene's intraday indicators

Clene intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Clene stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Daily Balance Of Power	9.2 T
	Rate Of Daily Change	1.23
	Day Median Price	0.0665
	Day Typical Price	0.0665
	Price Action Indicator	0.0063
	Period Momentum Indicator	0.0125

Clene time-series forecasting models is one of many Clene's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Clene's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Clene Stock media impact

Far too much social signal, news, headlines, and media speculation about Clene that are available to investors today. That information is available publicly through Clene media outlets and privately through word of mouth or via Clene internal channels. However, regardless of the origin, that massive amount of Clene data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of Clene news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Clene relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Clene's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Clene alpha.

Clene Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Clene can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.

Clene Nanomedicine Receives Patent Notic...

recently @ finance.yahoo.com

Bullish

Clene Nanomedicine Closes Merger with To...

recently @ finance.yahoo.com

Neutral

Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Clene without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Piotroski F Score Now

Piotroski F Score

Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals

All Next

Launch Module

Clene Corporate Management

Elected by the shareholders, the Clene's board of directors comprises two types of representatives: Clene inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Clene. The board's role is to monitor Clene's management team and ensure that shareholders' interests are well served. Clene's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Clene's outside directors are responsible for providing unbiased perspectives on the board's policies.

Robert MD	Chief Officer	Profile
Jeong Ted	Chief Officer	Profile
Mark ESQ	Chief Officer	Profile
Michael Hotchkin	Chief Officer	Profile
Rob Etherington	Pres CEO	Profile
Mark Mortenson	CoFounder Officer	Profile

How to buy Clene Stock?

Examine Clene's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Clene's leadership team and their track record. Good management can help Clene navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Biotechnology space and any emerging trends that could impact Clene's business and its evolving consumer preferences.
Compare Clene's performance and market position to its competitors. Analyze how Clene is positioned in terms of product offerings, innovation, and market share.
Check if Clene pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Clene's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

Already Invested in Clene Inc?

The danger of trading Clene Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Clene is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Clene. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Clene Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.

When determining whether Clene Inc is a strong investment it is important to analyze Clene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clene's future performance. For an informed investment choice regarding Clene Stock, refer to the following important reports: